STERIS Announces Financial Results for Fiscal 2026 Fourth Quarter and Full Year
STERIS plc reported a 7% increase in total revenue for Q4 FY 2026, reaching $1.6 billion, while full year revenue grew by 9% to $5.9 billion. Net income for Q4 was $220.3 million, compared to $146.5 million in Q4 FY 2025. Adjusted net income for the year was $1.0 billion. Healthcare and Applied Sterilization Technologies segments reported growth, though capital equipment revenue in AST declined sharply. Cash flow from operations improved to $1.34 billion, and free cash flow rose to $982.9 million.
DUBLIN, IRELAND, May 11, 2026 (GLOBE NEWSWIRE) — STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2026 fourth quarter and full year ended March 31, 2026. Total revenue from continuing operations for the fourth quarter of fiscal 2026 increased 7% to $1.6 billion compared with $1.5 billion in the fourth quarter of fiscal 2025. Constant currency organic revenue growth from continuing operations grew 5% in the fourth quarter.